1-17334004-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_012387.3(PADI4):āc.335G>Cā(p.Gly112Ala) variant causes a missense change. The variant allele was found at a frequency of 0.554 in 1,602,266 control chromosomes in the GnomAD database, including 247,750 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign,association (no stars).
Frequency
Genomes: š 0.54 ( 21992 hom., cov: 31)
Exomes š: 0.56 ( 225758 hom. )
Consequence
PADI4
NM_012387.3 missense
NM_012387.3 missense
Scores
1
2
14
Clinical Significance
Conservation
PhyloP100: 3.69
Genes affected
PADI4 (HGNC:18368): (peptidyl arginine deiminase 4) This gene is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. This gene may play a role in granulocyte and macrophage development leading to inflammation and immune response. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=9.706947E-5).
BP6
Variant 1-17334004-G-C is Benign according to our data. Variant chr1-17334004-G-C is described in ClinVar as [Benign, association]. Clinvar id is 972895.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.573 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PADI4 | NM_012387.3 | c.335G>C | p.Gly112Ala | missense_variant | 3/16 | ENST00000375448.4 | NP_036519.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PADI4 | ENST00000375448.4 | c.335G>C | p.Gly112Ala | missense_variant | 3/16 | 1 | NM_012387.3 | ENSP00000364597.4 | ||
PADI4 | ENST00000375453.5 | c.335G>C | p.Gly112Ala | missense_variant | 3/4 | 2 | ENSP00000364602.1 |
Frequencies
GnomAD3 genomes AF: 0.536 AC: 81347AN: 151744Hom.: 22001 Cov.: 31
GnomAD3 genomes
AF:
AC:
81347
AN:
151744
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.545 AC: 136995AN: 251246Hom.: 37763 AF XY: 0.549 AC XY: 74563AN XY: 135810
GnomAD3 exomes
AF:
AC:
136995
AN:
251246
Hom.:
AF XY:
AC XY:
74563
AN XY:
135810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.556 AC: 806606AN: 1450404Hom.: 225758 Cov.: 29 AF XY: 0.556 AC XY: 401926AN XY: 722384
GnomAD4 exome
AF:
AC:
806606
AN:
1450404
Hom.:
Cov.:
29
AF XY:
AC XY:
401926
AN XY:
722384
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.536 AC: 81371AN: 151862Hom.: 21992 Cov.: 31 AF XY: 0.538 AC XY: 39897AN XY: 74212
GnomAD4 genome
AF:
AC:
81371
AN:
151862
Hom.:
Cov.:
31
AF XY:
AC XY:
39897
AN XY:
74212
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2099
ALSPAC
AF:
AC:
2184
ESP6500AA
AF:
AC:
2143
ESP6500EA
AF:
AC:
4738
ExAC
AF:
AC:
66308
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign; association
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PADI4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Rheumatoid arthritis;C5441745:Abnormal pulmonary interstitial morphology Other:1
association, no assertion criteria provided | case-control | HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas | Feb 01, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
PrimateAI
Benign
T
PROVEAN
Uncertain
D;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Pathogenic
D;T
Polyphen
0.64
.;P
Vest4
MPC
0.14
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at